Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab Meeting Abstract
| Authors: | D'Angelo, S. P.; Fofana, F.; Schlichting, M.; Henry-Szatkowski, M.; Hennessy, M.; Bharmal, M. |
| Abstract Title: | Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy289.038 |
| Language: | English |
| ACCESSION: | WOS:000459277303053 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy289.038 |
| Notes: | Meeting Abstract: 1282P -- Appears on pages viii457-viii458 of the abstract book -- Source: Wos |
